Review |
From the Bioengineering Department, University of Washington, Seattle, Wash.
Correspondence to Cecilia M. Giachelli, PhD, Professor, Bioengineering, Box 351720, University of Washington, Seattle, WA 98195. E-mail ceci{at}u.washington.edu
This Review is part of a thematic series on Mechanisms of Vascular Calcificiation, which includes the following articles:
The Pathophysiology of Vascular Calcification in Chronic Kidney Disease
Mesenchymal Stem Cells and the Artery Wall
Regulation of Vascular Calcification by Osteoclast Regulatory Factors RANKL and OPG
Regulation of Vascular Calcification: Roles of Phosphate and Osteopontin
Angiogenesis and Pericytes in Initiation of Ectopic Calcification
Role of Bone Morphogenetic Proteins in Vascular Calcification
Linda Demer Guest Editor
Vascular calcification is prevalent in aging as well as a number of pathological conditions, and it is now recognized as a strong predictor of cardiovascular events in the general population as well as diabetic and end-stage renal disease patients. Vascular calcification is a highly regulated process involving inductive and inhibitory mechanisms. This article focuses on two molecules, phosphate and osteopontin, that have been implicated in the induction or inhibition of vascular calcification, respectively. Elevated phosphate is of interest because hyperphosphatemia is recognized as a major nonconventional risk factor for cardiovascular disease mortality in end-stage renal disease patients. Studies to date suggest that elevated phosphate stimulates smooth muscle cell phenotypic transition and mineralization via the activity of a sodium-dependent phosphate cotransporter. Osteopontin, however, appears to block vascular calcification most likely by preventing calcium phosphate crystal growth and inducing cellular mineral resorption.
Key Words: cardiovascular disease osteopontin phosphate pyrophosphate smooth muscle cell vascular calcification
This article has been cited by other articles:
![]() |
A. W.Y. Chung, H.H. C. Yang, J. M. Kim, M. K. Sigrist, E. Chum, W. A. Gourlay, and A. Levin Upregulation of Matrix Metalloproteinase-2 in the Arterial Vasculature Contributes to Stiffening and Vasomotor Dysfunction in Patients With Chronic Kidney Disease Circulation, September 1, 2009; 120(9): 792 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Parker, J. H. Ix, E. C. M. Cranenburg, C. Vermeer, M. A. Whooley, and L. J. Schurgers Association of kidney function and uncarboxylated matrix Gla protein: Data from the Heart and Soul Study Nephrol. Dial. Transplant., July 1, 2009; 24(7): 2095 - 2101. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mizobuchi, D. Towler, and E. Slatopolsky Vascular Calcification: The Killer of Patients with Chronic Kidney Disease J. Am. Soc. Nephrol., July 1, 2009; 20(7): 1453 - 1464. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Panizo, A. Cardus, M. Encinas, E. Parisi, P. Valcheva, S. Lopez-Ongil, B. Coll, E. Fernandez, and J. M. Valdivielso RANKL Increases Vascular Smooth Muscle Cell Calcification Through a RANK-BMP4-Dependent Pathway Circ. Res., May 8, 2009; 104(9): 1041 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Akat, M Borggrefe, and J J Kaden Aortic valve calcification: basic science to clinical practice Heart, April 1, 2009; 95(8): 616 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Prosdocimo, D. C. Douglas, A. M. Romani, W. C. O'Neill, and G. R. Dubyak Autocrine ATP release coupled to extracellular pyrophosphate accumulation in vascular smooth muscle cells Am J Physiol Cell Physiol, April 1, 2009; 296(4): C828 - C839. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Villa-Bellosta, S. Ravera, V. Sorribas, G. Stange, M. Levi, H. Murer, J. Biber, and I. C. Forster The Na+-Pi cotransporter PiT-2 (SLC20A2) is expressed in the apical membrane of rat renal proximal tubules and regulated by dietary Pi Am J Physiol Renal Physiol, April 1, 2009; 296(4): F691 - F699. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Ix, I. H. De Boer, C. A. Peralta, K. L. Adeney, D. A. Duprez, N. S. Jenny, D. S. Siscovick, and B. R. Kestenbaum Serum Phosphorus Concentrations and Arterial Stiffness among Individuals with Normal Kidney Function to Moderate Kidney Disease in MESA Clin. J. Am. Soc. Nephrol., March 1, 2009; 4(3): 609 - 615. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-u. Alam, J. P. Kirton, F. L. Wilkinson, E. Towers, S. Sinha, M. Rouhi, T. N. Vizard, A. P. Sage, D. Martin, D. T. Ward, et al. Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells Cardiovasc Res, February 1, 2009; 81(2): 260 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Atkinson Age-related medial elastocalcinosis in arteries: mechanisms, animal models, and physiological consequences J Appl Physiol, November 1, 2008; 105(5): 1643 - 1651. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Marhaug, V. Shah, R. Shroff, H. Varsani, L. R. Wedderburn, C. A. Pilkington, and P. A. Brogan Age-dependent inhibition of ectopic calcification: a possible role for fetuin-A and osteopontin in patients with juvenile dermatomyositis with calcinosis Rheumatology, July 1, 2008; 47(7): 1031 - 1037. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kristiansson, E. Ilveskoski, T. Lehtimaki, L. Peltonen, M. Perola, and P. J. Karhunen Association Analysis of Allelic Variants of USF1 in Coronary Atherosclerosis Arterioscler Thromb Vasc Biol, May 1, 2008; 28(5): 983 - 989. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. VanBavel and E. N.T.P. Bakker A Vascular Bone Collector: Arterial Calcification Requires Tissue-Type Transglutaminase Circ. Res., March 14, 2008; 102(5): 507 - 509. [Full Text] [PDF] |
||||
![]() |
O. Phan, O. Ivanovski, I. G. Nikolov, N. Joki, J. Maizel, L. Louvet, M. Chasseraud, T. Nguyen-Khoa, B. Lacour, T. B. Drueke, et al. Effect of oral calcium carbonate on aortic calcification in apolipoprotein E-deficient (apoE-/-) mice with chronic renal failure Nephrol. Dial. Transplant., January 1, 2008; 23(1): 82 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Eller, K. Hochegger, G. M. Feuchtner, E. Zitt, I. Tancevski, A. Ritsch, F. Kronenberg, A. R. Rosenkranz, J. R. Patsch, and G. Mayer Impact of ENPP1 genotype on arterial calcification in patients with end-stage renal failure Nephrol. Dial. Transplant., January 1, 2008; 23(1): 321 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cunningham, J. Floege, G. London, M. Rodriguez, and C. M. Shanahan Clinical Outcomes in Secondary Hyperparathyroidism and the Potential Role of Calcimimetics NDT Plus, January 1, 2008; 1(suppl_1): i29 - i35. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Orita, H. Yamamoto, N. Kohno, M. Sugihara, H. Honda, S. Kawamata, S. Mito, N. N. Soe, and M. Yoshizumi Role of Osteoprotegerin in Arterial Calcification: Development of New Animal Model Arterioscler Thromb Vasc Biol, September 1, 2007; 27(9): 2058 - 2064. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fliser, B. Kollerits, U. Neyer, D. P. Ankerst, K. Lhotta, A. Lingenhel, E. Ritz, F. Kronenberg, and for the MMKD Study Group Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease (MMKD) Study J. Am. Soc. Nephrol., September 1, 2007; 18(9): 2600 - 2608. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bostrom Osteopontin, a missing link in PDGF-induced smooth muscle cell migration Cardiovasc Res, September 1, 2007; 75(4): 634 - 635. [Full Text] [PDF] |
||||
![]() |
A. P. Burke, F. D. Kolodgie, and R. Virmani Fetuin-A, Valve Calcification, and Diabetes: What Do We Understand? Circulation, May 15, 2007; 115(19): 2464 - 2467. [Full Text] [PDF] |
||||
![]() |
R. Dhingra, L. M. Sullivan, C. S. Fox, T. J. Wang, R. B. D'Agostino Sr, J. M. Gaziano, and R. S. Vasan Relations of Serum Phosphorus and Calcium Levels to the Incidence of Cardiovascular Disease in the Community Arch Intern Med, May 14, 2007; 167(9): 879 - 885. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Brisset, H. Hao, E. Camenzind, M. Bacchetta, A. Geinoz, J.-C. Sanchez, C. Chaponnier, G. Gabbiani, and M.-L. Bochaton-Piallat Intimal Smooth Muscle Cells of Porcine and Human Coronary Artery Express S100A4, a Marker of the Rhomboid Phenotype In Vitro Circ. Res., April 13, 2007; 100(7): 1055 - 1062. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Kaartinen, M. Murshed, G. Karsenty, and M. D. McKee Osteopontin Upregulation and Polymerization by Transglutaminase 2 in Calcified Arteries of Matrix Gla Protein-deficient Mice J. Histochem. Cytochem., April 1, 2007; 55(4): 375 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Golledge, J. Muller, N. Shephard, P. Clancy, L. Smallwood, C. Moran, A. E. Dear, L. J. Palmer, and P. E. Norman Association Between Osteopontin and Human Abdominal Aortic Aneurysm Arterioscler Thromb Vasc Biol, March 1, 2007; 27(3): 655 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tonelli, F. Sacks, M. Pfeffer, Z.H. Gao, G. Curhan, for the Cholesterol and Recurrent Events (CARE) Tr, P. Rossing, K. Rossing, P. Gaede, O. Pedersen, et al. Serum Phosphate: A Novel Cardiovascular Risk Factor Even in Nonrenal Patients: Relation between Serum Phosphate Level and Cardiovascular Event Rate in People with Coronary Disease. Circulation 112: 2627-2633, 2005 J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2077 - 2085. [Full Text] [PDF] |
||||
![]() |
P. Pauletto and M. Rattazzi Inflammation and hypertension: the search for a link Nephrol. Dial. Transplant., April 1, 2006; 21(4): 850 - 853. [Full Text] [PDF] |
||||
![]() |
D. Hendig, V. Schulz, M. Arndt, C. Szliska, K. Kleesiek, and C. Gotting Role of Serum Fetuin-A, a Major Inhibitor of Systemic Calcification, in Pseudoxanthoma Elasticum Clin. Chem., February 1, 2006; 52(2): 227 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. Alexander, F. L. Wilkinson, J. P. Kirton, C. F. Rock, G. D.M. Collett, M. Jeziorska, J. V. Smyth, A. M. Heagerty, and A. E. Canfield Identification and Characterization of Vascular Calcification-Associated Factor, a Novel Gene Upregulated During Vascular Calcification In Vitro and In Vivo Arterioscler Thromb Vasc Biol, September 1, 2005; 25(9): 1851 - 1857. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |